Mixed incontinence.
Wein
Alan J
AJ
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D003408:Cresols / Q000627:therapeutic use*; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*; D000068737:Tolterodine Tartrate; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000188:drug therapy*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*; D014563:Urodynamics / Q000187:drug effects
D018759:Adrenergic Uptake Inhibitors; D001559:Benzhydryl Compounds; D003408:Cresols; D000068736:Duloxetine Hydrochloride; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes; D000068737:Tolterodine Tartrate